|
| Subscribe to Mad About Rheumatology |
| Visit this group |
From The Rheumatologist, For OA, 1.Topical rather than oral nonsteroidal antiinflammatory drugs (NSAIDs) should be used whenever possible for people over age 75 years, a recommendation in accord with the American Geriatric Society. 2.For hand OA, provision of assistive devices, use of thermal modalities and trapeziometacarpal joint splints, and use of oral...
2012 Update of the 2008 AC Recommendations for the use of DMARDs and Biologic Agents in the treatment of RA This new guidelines is supposedly an update of the 2008 guidelines in light of newer agents and evidence. Here are a few highlights from...
The risks of upper GI bleed due to non-steroidal anti-inflammatory drugs (NSAIDs) is well documented. However, many physicians are not aware about the risks of lower GI bleed in those taking NSAIDs. Perhaps most patients rarely complain about symptoms of lower GI bleed which can...
This subject has remained a thorn in the use of anti TNF biologic agents in autoimmune diseases. Below, we identified several studies which included a large number of patients....
To date, Rituximab ( a monoclonal anti CD20 antibody ) is licensed for use after failure of anti tumour necrosis factor alpha (TNFa), which remains as the first line...
The role of aspirin in cardiovascular disease is indisputable. However, its role in antiphospholipid antibody syndrome as a primary prevention of thromboembolism is more unclear.
Perhaps I am a novice to large conventions with the past EULAR being my first. However one gets a sense that such conventions are getting so large that it...
by Dr Raja Jasmin
A 46 year old Indian lady presented with an eight month history of intermittent fever, weight loss and symmetrical proximal muscle pain and weakness involving both...
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease which displays a broad spectrum of clinical and immunological manifestations, with recurrence and accumulation of manifestations over time and...
